Search form

Search form

HHS signed a contract initially valued at about $8 million with the public relations firm Weber Shandwick to promote the health insurance exchanges under the Affordable Care Act. An HHS official said the public relations agency will raise the profile of the exchanges through "a range of communications tactics, with an emphasis on paid media and digital outreach." The firm's work will be one element of a wider campaign by the HHS, the official added.

Related Summaries

DiaCarta, a Hayward, Calif-based developer of in vitro diagnostic tests, has obtained $8 million in a Series A funding round from the BioVeda China Fund. The company will use the money to expand its portfolio and commercialize its products. As part of the deal, BVCF's Weixin Xu will join DiaCarta's board.

Breakwater Investment has made an $8 million investment in Consensus Orthopedics. The California-based orthopedic device company will use the money to increase its portfolio of knee and hip replacement systems.

A U.K. initiative that aims to develop novel arterial stents and other biocompatible and biodegradable medical products has received a grant worth $8 million. The ReBioStent program, headed by health care consultancy group Ceram, started this year and will run for three years.

The Center for Personalized Cancer Therapy, a joint effort between the Dana-Farber/Harvard Cancer Center and the University of Massachusetts Boston, has received $8 million from the Massachusetts Life Sciences Center. Part of the proceeds will go toward a research program involving biomarker-based tests that can be used to differentiate cancer subtypes and predict patients' drug responses.

Semprus BioSciences has secured $8 million from 5AM Ventures and other private investors that joined a round of Series A funding. Semprus said it will use the money to further develop its antibacterial-coatings technology, including one that offers a stable surface structure for medical devices to lower risk of complications.